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Abstract 
RNA interference (RNAi) is a highly evolutionally conserved process of post-
transcriptional gene silencing (PTGS) by which double stranded RNA (dsRNA), when 
introduced into a cell, causes sequence-specific degradation of homologous mRNA 
sequences, siRNA (small interfering RNA are a class of 20-25 nucleotide-long double-
stranded RNA molecules) is involved in the RNA interference (RNAi) pathway where the 
siRNA interferes with the expression of a specific gene. We focus on the problem of gene 
family knockdown by using the minimal number of siRNAs. The problem is to determine 
the minimal number of siRNAs required to knockdown a family of genes targeted by 
these siRNAs. This is a minimal set covering problem, and hence it is NP-hard. In this 
thesis, we explore a number of heuristic optimization methods for the minimal siRNA 
covering problem. Such methods include evolutionary heuristics, as well as novel greedy 
methods, applied for the first time to the minimal siRNA cover problem. Preliminary 
experiments with genetic algorithms show significant reduction in the siRNA cover size, 
when compared with branch&bound and probabilistic greedy. We are currently 
implementing novel greedy methods which are variants of well-known feature subset 
selection algorithms. In such methods, we define criterion functions over a collection of 
siRNA subsets to help us decide which subset is best to be included in a candidate 
solution. 
We use three gene families: the FREP genes from Biomphalaria glabrata and the 
olfactory genes from Caenorhabditis elegans. We also conducted experiments on one 
artificial data set. 
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RNA interference (RNAi) was first discovered in 1998 by Andrew Fire and Craig Mello 
in the nematode worm Caenorhabditis elegans and later found in a widely number of 
organisms, including mammals. RNA interference (RNAi) plays both regulatory and 
immunological roles in the eukaryotic genetic system [1,2], and it also involved in both 
therapeutic and genomic applications because of its potentials in treatments for widely 
existed diseases such as HIV [3, 4], Huntington's diseases [5] and some certain types of 
cancers [6, 7]. RNA interference (RNAi) is a mechanism that inhibits gene expression at 
the stage of translation by hindering the transcription of specific genes. RNAi targets 
include RNA from viruses and transposons (significant for some forms of innate immune 
response), and work on regulating development and genome maintenance. Small 
interfering RNA strands (siRNA) play a key role in the RNAi process, and have 
complementary nucleotide sequences to the targeted RNA strand. Specific RNAi pathway 
proteins are guided by the siRNA to the targeted messenger RNA (mRNA), where they 
cleave the target, breaking it down into smaller portions which can not be translated into 
protein any more. A type of RNA transcribes from the genome itself, microRNA 
(miRNA), works in the same way [8]. 
Nowadays, RNAi research mainly focus on single gene knockdown. Gene knockdown 
relates to genetically modifying an organism whose goal is to have reduced expression of 
one or more genes in its chromosomes by inserting a reagent such as a short DNA or 
RNA oligonucleotide with a sequence complementary to an active gene or its mRNA 
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transcripts. This can lead to permanent modification of the chromosomal DNA to produce 
a "knockdown organism" or a temporary change in gene expression without modification 
of the chromosomal DNA molecules to knock down the function of a single gene. In this 
thesis, we want to knockdown a gene family with a minimal number of siRNAs because 
the efficacy of a specific siRNA in knocking down its target gene is determined by its 
homology to that gene. As the synthesis of individual siRNAs may cost hundreds or 
thousands of dollars, so using compact sets of siRNAs for gene family knockdown would 
have more advantages. 
Following association with an RNAi silencing complex, siRNA targets mRNA transcripts 
that have sequence identity for destruction. A phenotype resulting from this knockdown 
of expression may inform about the function of the targeted gene. However, off-target 
effects compromise the specificity of RNAi if sequence identity between siRNA and 
random mRNA transcripts causes RNAi to knockdown expression of non-targeted genes. 
The chance for off-target RNAi increases with greater length of the initial dsRNA 
(double strand RNA is RNA with two complementary strands sequence) , inclusion 
into the analysis of available un-translated region sequences and allowing for mismatches 
between siRNA and target sequences. siRNA sequences from within 100 nucleotide of the 
5' termini of coding sequences have low chances for off-target reactivity. This may be 
owing to coding constraints for signal peptide-encoding regions of genes relative to 
regions which encode for mature proteins. Off-target distribution varies along the 
chromosomes of Caenorhabditis elegans, apparently owing to the use of more unique 
sequences in gene-dense regions. Finally, biological and thermodynamical descriptors of 
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effective siRNA reduce the number of potential siRNAs compared with those identified 
by sequence identity alone, but off-target RNAi remains likely, with an off-target error 
rate of 10% [11]. In a word, we want to avoid off-target effects in which the siRNA 
causes unintended knockdown of an untargeted gene to which it incidentally has high 
homology. So our purpose is to select a minimal set of siRNAs that cover targeted genes 
in a family and do not cover any untargeted genes. This is a NP-Hard problem [9] since 
we can regard it as a set cover problem. In this paper, we introduce four heuristics for this 
problem: a genetic algorithm-based heuristic, a dominated target covering heuristic, a 
dominant siRNA selection heuristic and a forward selection heuristic. Our experiment 
results show that our methods significantly reduce the number of siRNA covers compared 
with other two algorithms: branch and bound, probabilistic greedy [9]. 
We implement our proposed methods on three gene families. The first family, which is 
the set of Fibrinogen-related protein (FREP) genes from the snail Biomphalaria glabrata 
are medically relevant because this snail is a model organism for infection by the human-
affecting parasite Schistosoma mansoni [9]. The second family is another set of FREP 
genes like family 1 [10]. And the data of third family, which is the olfactory genes of 
nematode Caenorhabditis elegans, is downloaded from NCBI [12]. 
Chapter 2 
2. Gene Knockdown 
Gene knockdown involves techniques through one or more of an organism's genes 
expression which is reduced by genetic modification (a change in the DNA of one of the 
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organism's chromosomes) or by treatment with a reagent, for instance: a short DNA or 
RNA oligonucleotide to either an mRNA transcript or a gene. The result is a: knockdown 
organism when genetic modification of DNA is done. If the change in gene expression is 
result from an oligonucleotide binding to an mRNA or temporarily binding to a gene, this 
leads to a temporary change in gene expression without modification of the chromosomal 
DNA and the result is as a: transient knockdown. 
Transient knockdown decreased expression through blocking transcription, degradation 
of RNA transcript and blocking either mRNA translation, pre-mRNA splicing sites or 
nuclease cleavage sites used for maturation of other functional RNAs such as miRNA [37] 
by binding oligonucleotide to the active gene or its transcripts. Transient knockdowns for 
learning about a gene have been sequenced as the most direct use. It also has an unknown 
or incompletely known function, an experimental approach known as reverse genetics. 
Researchers infer how the knockdown differs from individuals in which the gene of 
interest is operational by an experimental approach. Since oligos can be injected into 
single-celled zygotes and will be present in the daughter cells of the injected cell through 
embryonic development [38], transient knockdowns are often used in developmental 
biology. 
Heretofore, knockdown organisms with permanent alterations in their DNA have been 
applied mainly for research purposes. These organisms are most commonly used for 
reverse genetics such as mice or rats, because they cannot easily be applied through 
transient knockdown technologies. 
2.1 RNA Interference 
RNA interference refers to a mechanism in eukaryotic cells that leads to a specific 
posttranscriptional gene silencing in response to long double stranded RNA. In the cell 
the long dsRNA are cut into 21-25 bp pieces by an enzyme called DICER, a member of 
the RNase III family of dsRNA specific ribonucleases. The resulting small dsRNAs 
activates a large protein complex called the RNA-induced silencing complex (RISC) 
which, by using one of the strands as a guide, binds to the corresponding mRNA and 
degrades it, leading to a specific 'knock down' of protein expression. In vertebrate cells 
investigations of RNAi initially gave problems with the vertebrate interferon defense 
system, which by several complex pathways leads to an overall and therefore nonspecific 
cellular shut down of protein expression. As the interferon response is thought to be 
triggered only by dsRNAs longer than 30 bp, smaller dsRNAs about 21 base pairs long, 
termed small interfering RNAs or simply siRNAs, have been explored for the induction 
of specific RNAi in vertebrate cells. These smaller dsRNAs are thought to function as 
equivalents of the small dsRNAs cut by DICER. 
RNAi is an RNA-dependent gene silencing process that is controlled by the RNA-induced 
silencing complex (RISC) and is initiated by short double-stranded RNA molecules in a 
cell's cytoplasm, where they interact with the catalytic RISC component argonaute [14]. 
When the dsRNA is exogenous (coming from infection by a virus with an RNA genome 
or laboratory manipulations), the RNA is imported directly into the cytoplasm and 
cleaved to short fragments by the enzyme dicer. The initiating dsRNA can also be 
endogenous (originating in the cell), as in pre-microRNAs expressed from RNA-coding 
genes in the genome. The primary transcripts from such genes are first processed to form 
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the characteristic stem-loop structure of pre-miRNA in the nucleus, then exported to the 
cytoplasm to be cleaved by dicer. Thus, the two dsRNA pathways, exogenous and 
endogenous, converge at the RISC complex [15]. . 
2.1.2 Importance of RNAi 
Gene expression is the process by which the information encoded in a gene is converted 
into amino acid sequences. When a gene is expressed, DNA is transcribed into mRNA 
which then acts as a template for the production of proteins. Thus, degradation and 
regulation of mRNA help govern cellular mRNA and, therefore, protein levels that result 
from gene expression. Complete genomes are being sequenced for several organisms and 
there is an increasing need for studying gene behaviors and functions. Changes in 
phenotype, resulting from RNAi, gives information about the functions of the targeted 
gene. Therefore, a mechanism like RNAi, which employs existing cell machinery, is 
highly useful. RNAi is also becoming increasingly important in developing therapeutic 
applications for a number of diseases due to its potential for specific targeted silencing 
[23]. During gene expression, there are three stages where genes causing diseases can be 
controlled - transcriptional, post-transcriptional, and post-translational intervention. 
Traditionally, drugs for disease control have been targeted towards proteins, which occur 
in the posttranslational phase. RNAi targets the protein-producing mRNA and can thereby 
control disease earlier - in the transcription phase. RNAi has been successfully used to 
target diseases such as AIDS [24], neurodegenerative diseases [25], cholesterol [26] and 
cancer [27] on mice with the hope of extending these approaches to treat humans. 
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2.2 siRNA 
A nucleotide (nt) is a subunit of DNA or RNA and is made up of one of adenine (A), 
guanine (G), cytosine (C) or uracil (U) (in RNA) or thymine (T) (in DNA), along with a 
phosphate molecule, and a sugar molecule. The RNA molecule is formed from a 
sequence of these nucleotides. The complementary nucleotides of A, C, G and U are U, G, 
C and A respectively. When long dsRNA from an external source is introduced into the 
cell, it is recognized by Dicer, a member of the RNase III family of dsRNA-specific 
ribonucleases. Dicer cleaves the dsRNA to produce siRNA duplexes of lengths 19-21 nt 
[16]. Each siRNA strand has a 5' phosphate group and a 3' hydroxyl group and has a 2 nt 
overhang at the 3 ' end [17]. The siRNA duplex separates into sense and antisense strands 
and one of the strands is taken up by a RNA-protein complex, referred to as RISC [18]. 
HO 
OH 
Schematic representation of a siRNA molecule: a -19-
21basepair RNA core duplex that is folowed by a 2 
nucleotide 31 overhang on eacfi strand OH: 31 hyd ros 
P: 5! phosphate. 
Figure 1.1 Anatomy of an siRNA 
(From http://en.wikipedia.org/wiki/Image: SiRNA_structure2.jpg) 
Activation of RISC requires an ATP-dependent unwinding of the siRNA duplex. Both the 
sense and antisense strands of the siRNA are capable of directing RNAi but specificity 
depends on the anti-sense strand. The active RISC then targets mRNA transcripts that 
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have sequence complementarity with the siRNA sequence. The targeted mRNA 
sequences are cleaved into smaller fragments which are then degraded. This results in 
sequencespecific removal of mRNA in targeted genes, which are then not expressed at the 
protein level. Figure 1.2 graphically illustrates the RNAi pathway initiated by the 
introduction of dsRNA. The knockdown effects induced by RNAi are usually transient 
but using vectorbased delivery methods, stable RNAi can be induced. RNAi is not 
immediate and there is a time course associated with the process. RNAi has also been 
shown to be inheritable in C. elegans [19]. In mammals, it was observed that long 
dsRNAs, with lengths more than 30 nt activate the PKR kinase pathway in the cell, also 
known as the interferon response. This causes non-specific degradation of mRNA, and 
leads to apoptosis or cell death. However, using synthesized siRNAs of lengths 21 - 23 nt 
[20] does not evoke the interferon response and provides effective silencing by RNAi. 
t o n © sSsRMA 
0 RISC . ' 
AAA& ,̂A& 
^ ^ A A A A 
Figure 1.2 RNA Interference Pathway (From RNAiWeb.com) 
In addition to siRNAs, gene silencing can also be caused by micro RNAs (miRNA). 
miRNAs are small RNAs, processed from double stranded hairpin structures that are 
encoded in the genome, and are believed to be involved in gene regulation. Unlike 
siRNAs, which work by mRNA degradation, miRNA work by suppressing translation of 
mRNA to protein. miRNAs have been shown to function as siRNAs by binding to 
perfectly complementary mRNA sequences to cause degradation. On the other hand, 
siRNAs can act as mRNAs with 3 - 4 nt mismatches and G-U mismatches [21]. This 
demonstrates that it is only the degree of complementarity which determines the 
functionality of the siRNA or miRNA sequence [22]. However, the effects of miRNA-
like behavior of siRNAs on efficacy experiments have not been extensively studied so far. 
This work only deals with the siRNA and so this document will not delve in the details of 
miRNA, but it is important to note that they are closely related. 
2.2.1 siRNA Sequence Design 
Three different kinds of software are implemented in this thesis for the siRNA sequence 
design - BLOCK-iT™ RNAi Designer [28], siDirect [29] and TROD (T7 RNAi Oligo 
Designer) [30]. 
BLOCK-iT™ RNAi Designer [28] uses a patented algorithm. The reasonable scheme 
which is used by this software not only supposition but also based on the practical 
experiment results. The experiment certified that RNAi Designer can choose unique 
target sequences which will remarkably increase the probability of off-target genes. 
BLOCK-iT™ RNAi Designer identifies effective RNAi sequences then uses BLAST to 
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select from a widely organism specific database which can be ensured to eliminate the 
off-target RNAi sequences. 
Rational siRNA design is used by siDirect [29]. The general guide lines [31] are shown as 
follows: 
1. siRNA targeted sequence is usually 21 nt in length. 
2. Avoid regions within 50-100 bp of the start codon and the termination codon 
3. Avoid intron regions 
4. Avoid stretches of 4 or more bases such as AAAA, CCCC 
5. Avoid regions with GC content <30% or > 60%. 
6. Avoid repeats and low complex sequence 
7. Avoid single nucleotide polymorphism (SNP) sites 
8. Perform BLAST homology search to avoid off-target effects on other genes or 
sequences 
9. Always design negative controls by scrambling targeted siRNA sequence. The control 
RNA should have the same length and nucleotide composition as the siRNA but have at 
least 4-5 bases mismatched to the siRNA. Make sure the scrambling will not create new 
homology to other genes. 
By experimentally analyzing the silencing efficiency of 180 siRNAs targeting the mRNA 
of two genes and correlating it with various sequence features of individual siRNAs, 
Reynolds et al [32] at Dharmacon, Inc identified eight characteristics associated with 
siRNA functionality. These characteristics are used by rational siRNA design algorithm 
to evaluate potential targeted sequences and assign scores to them. Sequences with higher 
10 
scores will have higher chance of success in RNAi. Table 2.1 below lists the 8 criteria and 











Moderate to low (30%-52%) GC Content 
At least 3 A/Us at positions 15-19 (sense) 
Lack of internal repeats (Tm*<20iaC) 
A at position 19 (sense) 
A at position 3 (sense) 
U at position 10 (sense) 
No G/C at position 19 (sense) 












Table 2.1 Reynolds' rational design rules [32] 
TROD (T7 RNAi Oligo Designer) [30] is a web application that facilitates the design of 
DNA oligonucleotides for the synthesis of short interfering RNAs (siRNAs) with T7 
RNA polymerase. TROD looks for all occurrences of the sequence NzGNisC. The G and 
C nucleotides are required for efficient synthesis of the RNA by T7 RNA polymerase, 
since it strongly favours a G at the start site. From these sequences, the program generates 
both the sense and antisense strands of DNA oligos that will be used to produce the 
siRNAs in vitro. By definition, the 'antisense' DNA oligo encodes the antisense siRNA 
strand, and vice versa. The following (reverse complemented) T7 promoter is appended to 
the 3' ends of the DNA oligos: 5'-TATAGTGAGTCGTATTA-3'. 
After T7 transcription, the siRNA duplexes will look like the following: 
sense siRNA: 5'-GNNNNNNNNNNNNNNNNNNUUU-3' 
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antisense siRNA: 3'-NNCNNNNNNNNNNNNNNNNNNG-5' 
TROD, by default, appends an AA dinucleotide to the 5' end of the DNA 'sense' strand, 
since AT-richness is preferred at this site. The result (as shown above) is a UU 
dinucleotide overhang on the sense siRNA after T7 transcription. In addition, in order to 
destabilize the 5' end of the antisense siRNA (so as to direct it to the RISC complex), a U 
replaces the complementary C, producing a GU pair. 
2.2.2 Efficaciousness of siRNA 
From the current research, the result shows that not all possible siRNA can be synthesized 
against a specific target, but a subsection of them would take effect in causing any 
degradation [33] and more, all siRNA do not result in equal knockdown effects [33]. As 
we found out the efficacy of siRNA even in the same target mRNA differ in different 
target sites, here to select efficiency ones which are extremely functional causing a certain 
higher percentage of the target mRNA sequence to degrade. There is variance on the 
importance of each of these properties. Reynolds et al. [32] launched their siRNA 
knockdown experiments and concluded that properties of the target mRNA did not affect 
the efficacy of knockdown but be solely based on properties of the siRNA. However, 
other studies [34, 35] showed that secondary structure and thermodynamic features 
(related to stability) of the siRNA are also important determining factors of functionality. 
Up on most studies, siRNA with knockdown of greater than 80% of the target mRNA are 
considered highly efficient while threshold varies based on the required level of silencing. 
So to help designing siRNA sequences to highly efficient against target mRNA sequences, 
it is quite important to have siRNA efficacy prediction. 
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2.2.3 Specificity of siRNA 
To better design siRNA sequences, the specificity of it is equaled important with potency 
or efficacy. While maximum degradation of target mRNA is required, silencing of non-
target mRNA should be avoided. To achieve the objective of maximally degrade target 
mRNA, avoid silencing of non-target mRNA is needed. As siRNA gene silencing is 
considered to be highly sequence-specific, even one single base mismatch would ruin 
gene silencing [20], while we can show the evidence in cultured human cells with eleven 
complementary matches out of 19 nucleotides of a siRNA is enough causing silencing 
[36]. This shows siRNAs may interact with limited sequence similarity and mentions us 
to give necessary consideration on siRNA specificity in design algorithms. Qiu et al. [11] 
have examined the effects of siRNA lengths on off-target error rates. 
2.3 Gene Family Knockdown 
At present, the focus of RNAi research has been put on single gene knockdown, which 
refers to genetically modifying an organism with intention to reduce expression of single 
or multiple genes in their chromosomes by inserting a reagent with a sequence 
complementary to an active gene or its mRNA transcripts, the most typical represent is a 
short DNA or RNA oligonucleotide. The impacts of gene knockdown will permanently 
modify the chromosomal DNA to produce a "knockdown organism" or a temporary 
change in gene expression without modification of the chromosomal DNA molecules to 
knock down the function of a single gene. In this thesis, we are trying to solve the 
problem which is using a minimal number of siRNAs to knockdown a gene family. The 
reason is the efficacy of a specific siRNA in knocking down its targeted gene is 
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determined by its homology to that gene. Further more, the synthesis of individual 
siRNAs may cost large amount of money, so using compact sets of siRNAs for gene 
family knockdown would bring more efficiency and profit. 
Because of its generally high specificity to a single target mRNA, RNAi has so far been 
primarily used to target and knock down the expression of individual genes in isolation. 
Often, however, it is useful to be able to knock down multiple genes simultaneously. For 
example, a family of closely related genes may have mutually redundant function; to 
observe any phenotypic change, it may be necessary to suppress the entire family 
simultaneously. For single gene knockdown, it usually suffices to select a substring of the 
target mRNA as the initiator siRNA. For families of genes, however, it is less clear how 
to design an optimal set of siRNAs to target the entire family. 
2.4 Problem Statement 
Given an siRNA covering problem instance {S, G, W}, we want to find the minimum set 
of siRNAs required to knock down all the target genes. We define the problem as follows: 
2.4.1 Minimal siRNA Selection Problem 
Given a siRNA set, S = {si,...,sN}, and a gene set, G - {gi,...gic}, a NxK matrix W=fwyJ 
is generated such that wy= 1 if s7 cover gh otherwise wy= 0. By doing this, we can transfer 
the minimal siRNA set cover problem to simple set covering problem. Table 2.2 shows an 
example of a matrix with the number of siRNAs N-l and the number of genes K=6. First, 
we generate this matrix from the original sequences of siRNAs. For example, gi and g3 
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have the same siRNA sequences: si=CACUCUACUGCAGCAAAGC; g2, g3 and g6 have 
the same siRNA sequences: s2=GUGGGAGCGCGUGAUGAAC. Then for the first 
column: wn=l, W3i=l, and wu=0 for other elements; for the second column: W22=1, 
W32=l, W62=l, and w;2=0 for other elements. With the off target effect genes: g4, gs and g$, 
we should not select column 2, 4 and 5, because those genes include S2, S4 and S5. Table 



















































































Table 1.3 Example of a matrix without off target effects. 
Given a matrix W, the objective of the minimal siRNA set cover problem is to find a 
minimal set of siRNAs that can cover all the target genes without covering any off target 
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genes. In Table 2.2, for instance, {S3, S6} is an optimal solution, while the solution {si, S3, 
S7} is not, and therefore it is not cost effective. 
The definition for minimal siRNA set cover problem is that, given a NxK matrix W with 
a siRNA set, S- {si, ...,SN} and a gene set G= {gb-.-gic}, the goal of the minimal siRNA 
set cover problem is to select a subset Smin c S of siRNAs such that 1) Smin is minimal, and 
2) Smin covers all the target genes without hitting any off target genes. In [9], this was 
proved to be an NP-hard problem by performing a reduction from the set covering 
problem. 
This problem can be formulated as an integer linear programming (ILP) problem as 
follows: 
N 
Minimize: 2_jXj (1) 
N 
Subject to: ^WijXj>l i=l,...,K (2) 
x,e{0,l} j=l,...,N (3) 
Variables JC,=1 when siRNAy is selected, otherwise XJ=0. 
In this thesis, we solve the above ILP problem by using three deterministic greedy 
heuristics and a genetic algorithm. 
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Chapter 3 
3. Overview of Existing Techniques 
This chapter gives an introduction for set cover problem. There is plenty of research has 
already done on set cover problem. A number of existing exact and approximate methods 
for it, including greedy heuristics [39, 40], Lagrangean relaxation [41], exact branch & 
bound, probabilistic greedy [9] and genetic algorithms [42, 43]. This section is followed 
by the discussion of these methods. 
3.1 Chvatal Heuristic 
This idea is to Let A be a binary matrix of size m X n, let cT be a positive row vector of 
length n and let e be the column vector, all of whose m components are ones. The set-
covering problem is to minimize cTx subject to Ax ^ e and x binary. Then compare the 
value of the objective function at a feasible solution found by a simple greedy heuristic to 
the true optimum. It turns out that the ratio between the two grows at most logarithmically 
in the largest column sum of A. 
3.2 Lagrangean relaxation 
In Beasley [41], the author consider the set covering problem (SCP) which is the problem 
of covering the rows of a m-row, n-column, zero-one matrix( ay) by a subset of the 
columns at minimum cost. Formally, the problem can be defined as follows: 
Let 
Xj= 1 if column j (cost q) is in the solution, 
Xj = 0 otherwise, then the program is: 
n 
minimise ^CJXJ (4) 
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n 
subject to ^aijXj>\, i=l,...,m, (5) 
XjG(0,l), j=l,...,n. (6) 
Equation (4) ensures that each row is covered by at least one column and equation (6) is 
the integrality constraint. The author presents a three stage algorithm consisting of: 
(I) A dual ascent procedure: 
Letting Uj (^0 , i=l, •••, m) be the dual variables associated with equation (5) then the 
dual of the linear programming relaxation of the SCP (DLSCP) is given by 
m 
minimise ^w (7) 
m 
subject to ^atjui ^Cj, i = 1,...,n, (8) 
i=i 
Ui>(), i=l,...,m. (9) 
The author adopted a two pass procedure to the problem of generating a good lower 
bound for the SCP from a feasible solution for DLSCP. This procedure was modelled on 
the dual ascent procedure of Balas and Ho [44]. At the end of this procedure, there will be 
a set of dual variables feasible for DLSCP and a corresponding lower bound as given by 
equation (7). 
(II) A sub gradient procedure starting from an initial set of lagrangean multipliers equal to 
the dual variables from stage (I): 
(III) Solving the dual of the linear programming relaxation of the SCP: 
(a) Generate an upper bound, 
(b) Use the dual ascent procedure to calculate an initial set of lagrange multipliers, 
(c) Use the subgradient procedure in an attempt to improve upon the bound derived from 
the dual ascent procedure, 
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(d) At the end of the subgradient procedure optimally solve DLSCP using a simplex 
algorithm. 
Note here that the third stage is achievable computationally because a comprehensive set 
of problem reduction tests are used to remove some rows, and a large number of columns, 
from the problem. 
3.3 Exact Branch and Bound Algorithm 
The minimal siRNA cover problem can be solved using branch-and bound techniques. A 
search tree is constructed by iteratively picking an siRNA and branching on it. At each 
point the algorithm generates two subtrees with one corresponding to selecting the siRNA 
and the other to de-selecting the siRNA. When an siRNA is selected, deduction 
techniques are used to reduce the search space. During the search, the algorithm keeps 
track of the current best cover with the lowest number of siRNAs. 
The Algorithm below shows the pseudocode for the exact, branch-and-bound process. S 
is the set of unselected siRNAs, and M is the set of uncovered target genes. The argument 
rank contains ranks for all the siRNAs. x is the current selection of siRNAs and b is the 
best selection found so far. The algorithm starts with (S, M, rank, 0, 1), where and 
represent vectors with all 0s and all Is, respectively. 
In step 4, we use Lemma 3 [9], which is proposed by Zhao et al. 2004, allows us to prune 
branches which cannot lead to any covers better than the known best one. 
Branch and Bound Algorithm: 
1. Branch_and_Bound (S, M, rank, x, b) { 
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2. Reduce S/M and update x 
3. Sort the rest of the siRNAs in non-increasing order of uncovered genes they can 
cover 
4. Compute the lower bound on the current path based on Lemma 3 [9] 
5. if (the lower bound > I b I or the low bound >Number_From_Greedy) {return b} 
6. if( | M | = 0 ) {returnx} 
7. si = first (S) 
8. y = Branch_and_Bound (S - {si}, M - g(sl), rank, x, b) 
9. if ( I y I < I b I or ( | y I = I b I and avgRank(y, rank) > avgRank(b, rank))^ 
{b=y} 
10. y = Branch_and_Bound (S - {si}, M, rank, x, b) 
11. if ( I y I < I b I or ( I y I = | b | and avgRank(y, rank) > avgRank(b, rank))= 
{b=y} 
12. return b 
13.} 
During the reduction stage, the algorithm discards any dominated siRNA, which covers 
only a subset of genes also covered by another siRNA. An essential siRNA is an siRNA 
which is the only one that can cover a particular target gene. We add all essential siRNAs 
to the solution x since they must be in any complete cover. We update the uncovered 
genes M accordingly. 
After reduction is done, the potential lower bound on the current path is estimated based 
on Lemma 3 [9]. If the current estimate requires more siRNAs than the current best cover 
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b, then we prune the current path. Otherwise, it generates two branches, one for selecting 
the next siRNA and the other for de-selecting the same siRNA. Simultaneously, the 
algorithm uses as the upper bound the number of siRNA in the cover obtained from our 
greedy algorithm to prune some paths since the minimal cover must be no worse than the 
one obtained from any greedy algorithm. 
3.4 Probabilistic Greedy Algorithm 
The probabilistic greedy algorithm [9] shares some common aspects with the randomized 
greedy algorithm [45], but it differs in an important way. The randomized greedy 
algorithm [45] uses a uniform probability distribution to select the next candidate to the 
cover, while this approach selects the next siRNA randomly according to a domain-
specific non-uniform probability distribution. Let f(s) be the number of genes that an 
siRNAs covers, and h(g) be the number of siRNAs which cover a particular gene g. 
Based on the two features: f(s) and mingeg(S)h(g), the author define a selection metric for 
selecting siRNAs, and then construct a subset of the unselected siRNAs as the set of 
potential siRNAs based on the selection metric and limiting parameter aG[0, 1]. They 
compute a selection probabilistic distribution over the potential siRNA set. 
The selection metric for siRNA, s, found to be the most effective is: 
milWw Kg) 
The selection probability distribution over the set of potential siRNAs S' is defined as: 
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The Algorithm below shows the pseudocode for the probabilistic greedy algorithm. S is a 
set of siRNAs, and M is the set of the target genes. The argument rank contains ranks for 
all the siRNAs: 
1. ProbGreedy (S, M, rank) { 
2. a = aValue / /a£[0, 1] 
3. k = aValue //Number of repetition 
4. opt = S 
5. iter = 0 
6. while (iter < k = { 
7. C = 0 
8. while (M ^0) { 
9. MAX = 0 
10. for each s e S { 
11. Compute metric m(s) 
12. if ( MAX < m(s) ) MAX = m(s) 
13. } 
14. S'=o 
15. for each s e S 
16. if (m(s) > a * MAX) S'= S' U {s} 
17. Compute probability distribution P(s) over S' 
18. Select s randomly from S' according to P(s) 
19. C = C U {s} 
20. S = S - {s} 
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21. M = M-g(s ) 
22. } 
23. Remove redundant siRNAs from C 




27. return C 
28. } 
This procedure is repeated k times from line 6 to 27, and returns the best siRNA cover it 
finds. Whenever there is a tie between two siRNA covers, the algorithm uses their 
average ranks as a tie-break, and chooses the one with the higher average rank. Since 
there are up to min( I M I , I S I ) siRNAs in an siRNA cover, thus, the inner while 
loop could have up to min( I M I , I S I ) iterations, where each iteration requires O(S) 
time. Therefore, the algorithm requires 0(k* I S I * min( I M I , I S I )) time. The 
probabilistic greedy algorithm reduces to standard greedy algorithm, when a=1.0 and k=l. 
3.5 Genetic Algorithm 
This Genetic algorithm [42] made some modifications to the basic genetic procedures 
including a new fitness-based crossover operator, a variable mutation rate and a heuristic 
feasibility operator accommodated specifically for the set cover problem. 
A genetic algorithm (GA) can be understood as an "intelligent" probabilistic search 
algorithm which can be applied to a variety of combinational optimisation problems [45]. 
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The theoretical foundations of GAs were originally developed by Holland [46]. The idea 
of GAs is based on the evolutionary process of biological organism in nature. During the 
course of the evolution, natural populations evolve according to the principles of natural 
selection and "survival of the fittest". Individuals which are more successful in adapting 
to their environment will have a better chance of surviving and reproducing, whilst 
individuals which are less fit will be eliminated. This means that the genes from the 
highly fit individuals will spread to an increasing number of individuals in each 
successive generation. The combination of good characteristics from highly adapted 
ancestors may produce even more fit offspring. In this way, species evolve to become 
more and more well adapted to their environment. 
A GA simulates these processes by taking an initial population of individuals and 
applying genetic operators in each reproduction. In optimisation terms, each individual in 
the population is encoded into a string or chromosome which represents a possible 
solution to a given problem. The fitness of an individual is evaluated with respect to a 
given object function. Highly fit individuals or solutions are given opportunities to 
reproduce by exchanging pieces of their genetic information, in a crossover procedure, 
with other highly fit individuals. This produces new "offspring" solutions, which share 
some characteristics taken from both parents. Mutation is often applied after crossover by 
altering some genes in the strings. The offspring can either replace the whole population 
(generational approach) or replace less fit individuals (steady-state approach). This 
evaluation-selection-reproduction cycle is repeated until a satisfactory solution is found. 
The basic steps of a simple GA are shown below: 
Generate an initial population; 
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Evaluate fitness of individuals in the population; 
Repeat 
Select parents from the population; 
Recombine (mate) parents to produce children; 
Evaluate fitness of the children; 
Replace some or all of the population by the children; 
Until a satisfactory solution has been found. 
Chapter 4 
4. Methodologies 
It is well known that heuristic method is extremely important for the present and future 
developments of bioinformatics, since it can provide key solutions for the new challenges 
posed by the progressive transformation of biology into data analysis. There are four 
heuristic methods are presented in this paper to solve the minimal siRNA set cover 
problem. 
4.1 Dominated Target Covering Heuristic (DTC) 
To select a minimal number of siRNAs STO„-covering each target gene, DTC uses a 
function to evaluate each individual siRNA. Given a matrix W which is determined by a 
siRNA set S={si, •••SN} and a gene set G={gi, •••gKJ, we define the cover function cov as 
follows: 
c o v f ^ g , . ) ^ * ^ s.eSgi,gieG ( 1 Q ) 
where 0^cov(sj,gi)^l and Sgi (Sgi denotes the number of siRNAs generated by each gene, 
so it is impossible to be empty)is the set of siRNAs related to gene g,-. The value of 
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covfogj) is considered as a ratio by which Sj contributes to the satisfaction of coverage 
constraint for gene g,-. 
Since the minimal number of siRNAs is to be selected, it is suitable to take into 
consideration each siRNA with regard to its capability of satisfying coverage constraints. 
After applied Equation (10), the coverage is calculated as: 
C(sj) = max{cov(sj,gi]l<i<k) gt e GSJ 
where Gsj is the set of genes covered by sj, C(sj) is the maximum contribution made by Sj 

























Table 4.1 Example of a coverage function table. 
When C(SJ) = 1, we consider sj as an essential siRNA since any feasible solution has to 
include it. In Table 4.1, it is obvious that S3 is an essential siRNA. 
This heuristic consists of three phases: initialization, construction and reduction. Initially, 
we calculate C(s) for each siRNA seS from the given matrix W. Then an initial non-
feasible solution Smiis created, which only contains essential siRNAs. We denote S as the 
set Sj, Ssoiis the subset of S which contains selected Sj in the next phase. In the construction 
phase, we always select the high-ratio siRNAs sj into Sini by sorting 5Vw in descending 
order of C(s). Note that, when we select a Sj&S\Ssoi that covers g„ we delete sy from 
matrix W, and then we compute C(s) from the reduced matrix W. This step executes 
repeatedly until we get an initial feasible solution. In the reduction phase, Ssoi is reduced 
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by repeatedly removing low-ratio siRNAs to achieve a feasible but near optimal solution 
Smin which is selected to cover all the target genes. 
More precisely, the steps of the heuristic can be described as follows: 
1. Initialization Phase 
a) compute C(s) for all s £ S 
b) Sini = {s&S | C(s)=\} {essential siRNAs in initial solution} 
2. Construction Phase 
d) sort S£soi in descending order of C(s) 
e) for each gene g; not covered by Ssoi 
Ssoi = Ssoi U sj {next highest-ratio sy£ .SV̂ o/ that covers g,-} 
f) delete sj from matrix W; 
g) repeat step a) to step f) 
3. Reduction Phase 
i)W=W\ Smi„ /*the restriction of matrix W to the siRNAs in Smin */ 
j) compute C(s) for all s^Smin 
k) sort Sde/ ={s£5OT,-„ I C(s)<\} in ascending order of Cfij 
1) if Smin\{s} is feasible for each s £ 5^/ then 
m) return Smin 
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In the worst-case, the time complexity of DTC is dominated by the construction phase. 
The time complexity of the construction phase is dominated by sorting in step d) and the 
search for siRNAs to cover some genes in step e). Sorting the siRNAs in e) takes O (n 
logn). In step e), there are potentially K genes that are not yet covered by Ssoi. Testing a 
gene for coverage takes at most n steps. Searching for the highest-degree siRNA Sj to 
cover a gene gi takes at most n steps. Therefore, step e) takes O (nk). The construction 
phase iterates n times at most (see step g)). Therefore, the construction phase runs in 
O (n2k) + O (n2 logn). 
4.2 Dominant siRNA Selection Heuristic (DSS) 
We also want to satisfy the selection of dominant siRNAs; sj dominates si if Gsi c GSJ. In 
Table 2.3, for example, si dominates S6 since Gs6={gi} c Gsi={gi,g3}. Selecting 
dominant siRNAs instead of dominated siRNAs covers more genes. In the example, 
however, we have C(si)=C(s6), and hence DTC will select si for gene coverage rather 
than S6 which depends on the particular order of the siRNAs. This is because DTC will 
select a dominant siRNA Sj over its dominated siRNA si only if C(sj)>C(s\). In Table 2.3, 
S6 dominates S7 and C(s6)>C(s7), therefore S6 will be selected first. 
To satisfy the selection of a dominant siRNA that has the same degree as some of its 
dominated siRNAs, we modify Equation (10) in such a way that a dominant siRNA Sj will 
have a higher C(s) value than its dominated siRNAs. We solve this by adding a penalizing 
each entry in Table 4.1 with an amount that takes into account the number of coverd 
genes. The new cov function has the form as follows: 
c o v ^ g , - ) - ^ * ^ * - ^ sjeSg,, gteG 
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(12) 
where 0 =S= cov(sj,gi) ̂  1, Sgi is the set of siRNAs related to gene gi, Gsj in the penalty term 
is the set of genes covered by Sj and m is the number of genes. In Equation (12), siRNAs 
that cover fewer genes are penalized more than those that cover more genes. 
Dominant siRNA Selection (DSS) heuristic is similar to DTC heuristic described in 
Section 4.1 only with the exception that function C is defined by using Equation (12) 
instead of Equation (10). In DSS, siRNAs that cover dominated genes are selected first, 
as in DTC. Unlike DTC, dominant siRNAs among all such siRNAs will be selected first. 
These two greedy principles together allow a larger coverage at each selection step. So 
DSS is greedier than DTC. 
4.3 Genetic Algorithm for Minimal siRNA Set Cover Problem 
Beasley et al. [41] presented a genetic algorithm-based heuristic for set covering problem. 
Based on this method, our GA inherits the siRNA selection function defined in Section 
4.2. The improved genetic approach can be illustrated in details as follows. 
4.3.1 Representation and Fitness Function 
To design a genetic algorithm, we have to devise a suitable representation scheme at first. 
Given the initial candidate siRNA set S= {SI,...,SN}, we want to find a feasible subset 
Smi„<zS of minimal cardinality. Therefore, the search space is the power set of S, denoted 
by 2 ; that is the set of all subsets of S. The fitness of an individual 5 is related to its 
objective value, which corresponds to the number of siRNAs in its associated subset. So 
the fitness function is: 
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/ = ! > (13) 
where sy is the value of the j-th bit (column) in the string (row) corresponding to the i-th 
individual. 
4.3.2 Parent Selection Operator 
For the purpose of selecting the fittest individuals continuously, we apply a binary 
tournament selection which selects the best individual in any tournament. The chosen 
individual will be removed from the population, otherwise individuals can be selected 
more than once for the next generation. 
4.3.3 Crossover Operator 
We implement the fusion operator of [41] which regards both the structure and the 
relative fitness of each parent solution, and produces a single child only. This crossover 
focuses on the differences of the parents. So it will generate new solutions more 
efficiently when they have similar parents. Besides, the fittest parent will obtain more 
probability to contribute the fitness of the child. Let fs and fspl be the scaled fitness 
values of the parents P\ and Pj respectively, and let C denote the child solution, then for 
eachj e [1,N]: 
1. IF Py = P2j, THEN Cj = Py = P2f, 
2. ELSE 
f 
(1) Cj = Py with probability p = / " s 
J pi J pi 
(2) Cj = Py with probability 1 - p 
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4.3.4 Mutation Operator and Variable Mutation Rate 
In the next step of crossover, we use the mutation operator to change a number of bit 
positions randomly. The number of positions to mutate for a given solution depends on 
the mutation rate. We use the variable mutation rate in [41]. It essentially depends on the 
rate of the GA convergence which means lower mutation rates are used in early 
generations. When mutation increases to higher rates, the population converges, after that 
mutation stabilizes to a constant rate. The mutation schedule below specifies the number 
of bits to mutate [41]. 
Nuntn m/ (14) 
1 + exp(- 4mg(t - mc)/mr) 
where / is the number of child solutions that have already been generated, my specifies the 
final stable mutation rate, mc is the number of solutions that should be generated such that 
the mutation rate i s ^ _ , and mg specifies the gradient at / = mc. The value of m/is user-
2 
defined and the values of mc and mg are problem-dependent parameters. 
4.3.5 Heuristic Feasibility Operator 
Crossover and mutation operators can generate unfeasible solutions. Hence, we propose a 
heuristic feasibility operator that keeps the feasibility of solutions in the population. More 
over, the operator provides a local optimization method for fine-tuning the results 
generated from crossover and mutation operators. This operator consists of the last two 
phases of DSS heuristic: construction and reduction phases. GA has already generated a 
potentially good solution Ssoi so we do not need to apply the initialization phase for this 
step. The construction phase starts with such a solution Ssoi which is not a feasible 
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solution generated by GA. The feasibility operator is applied for unfeasible solutions 
only. 
4.3.6 The Algorithm 
This Genetic Algorithm can be summarized as follows: 
1) Generate an initial population of N solutions. Set t:=0. 
2) Select two solutions St and S2 from the population using binary tournament 
selection. 
3) Produce a new solution C using the fusion crossover operator. 
4) Mutate Nummut randomly selected bits in C. 
5) Make C feasible and remove redundant columns in C by using DSS heuristic 
operator. 
6) If C is identical to any one of the solutions in the population, go to step 2; 
otherwise, set t:~t+l and go to step 7. 
7) Replace a randomly selected solution with an above average fitness in the 
population by C. 
8) Repeat steps 2-7 until t=Ps. {t is the number of child solutions that have already 
been generated, Ps is the population size which is a user defined parameter). 
4.4 Forward Selection Heuristic 
Forward Selection begins from an empty set of features. It first evaluates all one-feature 
subsets and selects the one with the best performance. Then evaluates all two-feature 
subsets that include the feature already selected in the first step and selects the best one. 
This process will continue until extending the size of the current subset leads to a lower 
performance. The steps of forward selection heuristic are shown as follows in detail: 
1) Use Equation (12) to select a ,sy with the best value (the highest value of C(s)). For 
instance, si is selected. 
32 
2) From all possible two-dimensional vectors that contain Sj form the fist step, that is, 
T rp rp rp 
[si, S2] , [si, S3] , [si, S4] ...[si, Sj] , compute the criterion value for each of them and 
select the best one, give an illustration: [si, s j 1 . 
3) Form all three-dimensional vectors generated from the two-dimensional winner ([si, 
S4]1), that is, [si, S4, S2]T, [si, s4; S3]
T, [si, S4, Ss]T.. .[si, S4, Sj]T and select the best one. 
4) Continue this procedure, until find a subset of S which can cover all the target 
genes with the minimal number ofay. 
5) In case that S may include redundant siRNAs, the last phase of DSS: reduction 
phase will be used in this step. 
The time complexity for step 1) is O (n2k), from step 2) to step 4) the time complexity 
is O (n). While, the reduction phase of DSS is implemented in step 5). So the total 
time complexity for forward selection is O (n2k+n+nlogn). 
Chapter 5 
5. Computational Experiment Results 
The experiments were conducted to find minimal siRNA sequences to cover all the target 
genes. As a set cover problem, we have a matrix and the goal is to select minimal 
columns to cover all the rows. We tested our heuristic methods on three gene families and 
an artificial matrix. During the experiments, each method was carried out consistently in 
the same environment using the same dataset. 
5.1 Experiment Environment 
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We implemented all approaches, and experimental results show that our heuristic 
approaches are good alternatives for the minimal siRNA set cover selection problem 
heuristics: exact branch and bound algorithm, probabilistic greedy algorithm [9]. All 
heuristics were implemented by Java programming language. 
The hardware platform is as follows: 
• A workstation with Intel(R) Xeon(TM) CPUs 3.20GHz and 3.19GHz 
• 8.00GB of RAM 
• The operating system is Microsoft Windows XP, Professional x64 Edition. 
5.2 Dataset 
In this thesis, we apply our methods to three gene families. The first family, the set of 
Fibrinogen-related protein (FREP) genes from the snail Biomphalaria glabrata, is of 
interest in human immunological studies because both humans and B.glabrata may 
become infected by the parasite Schistosoma mansoni [9]. The second family is also a set 
of FREP genes like family 1[10]. And for the third family, we downloaded the olfactory 
genes of nematode Caenorhabditis elegans from NCBI [12]. Fibrinogen-related proteins 
(FREPs) are in the hemolymph of the freshwater gastropod Biomphalaria glabrata. They 
are produced in hemocytes. Some categories of FREPs are modulated following infection 
with parasites such as the digenetic trematode Echinostoma paraensei. Some FREPs are 
capable of binding to parasite surfaces and can precipitate soluble parasite antigens, 
prompting hypothesis that they take into effect in internal defense [17]. The defense 
responses of B.glabrata are a relational concern since this snail is one of the most 
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important intermediate hosts for another digenetic trematode, Schistosoma mansoni, a 
parasite which infects about 83 million people [18]. Studying of molecules or genes 
involved in snail response to trematode infection will be very helpful for understanding 
the underlying mechanisms of the snail host and parasite interaction. 
The actual target gene families used in our experiments are: 
• Target family 1: 13 FREP genes from Zhao et al. [9]. 
• Target family 2: 53 fibrinogen (FBG) genes from the FREP family in Zhang et al. [10]. 
• Target family 3: 150 olfactory genes from NCBI [12]. 
5.3 Experiment Results 
We design the siRNA sequences for above 3 gene families by three softwares [28, 29, 30]. 
5.3.1 Experiments on using BLOCK-iT™ RNAi Designer 
Table 5.1, 5.2 and 5.3 show the number of siRNAs used for covering target genes. In 
these tables, G is the number of target genes, S is the number of siRNA sequences 
without off target gene effects. (Some abbreviations are used: PG=Probabilistic Greedy, 
BB=Branch & Bound, DTC=Dominated Target Covering, DSS=Dominant siRNA 























































































































































































































































































Table 5.3 Results for Target Family 3 (BLOCK-iT™ RNAi Designer). 
5.3.2 Experiments on using siDirect 



















































































































































































































































































































Table 5.6 Results for Target Family 3 (siDirect). 
5.3.3 Experiments on using TROD (T7 RNAi Oligo Designer) 































































































































































































































































































Table 5.10 Results for an Artificial Matrix. 
5.3.4 Summary of Experiments on Different Designed Sequence 
and Results 
Experiment results show that our heuristics are able to select less number of siRNAs than 
the methods mentioned in [9]. Since the three siRNA software designers use different 
algorithms, we got different siRNA sequences from each designer. Therefore, the 
numbers of the siRNA sequences are all different. When the number of siRNA increases, 
DSS, GA_DSS and FS give much better results than other methods. From the artificial 
dataset, we can clearly notice that the contrast between DSS, GA_DSS, FS and PG, BB is 






In this thesis, we discussed some heuristic approaches for the minimal siRNA set cover 
problem which is important to gene family knockdown. We introduced a novel heuristic 
method: forward selection for set covering problem and we also implemented other three 
improved methods. 
Experiment results showed that these methods are able to obtain relative minimal 
solutions which are still comparable to the known heuristics [9] for this problem. Hence, 
our methods can significantly reduce the number of siRNAs required in gene family 
knockdown experiments as compared to knocking down genes one by one. 
The experiments showed that it is a nice application of set cover heuristics to a recent 
biological problem. The modifications made to suit the problem were well thought out 
and the novel forward selection heuristic was promising. 
6.2 Future Work 
There are some directions for further work. We summarize as follows: 
• Applying some other siRNA sequence design software to compare the output 
sequences which are generated by these software. 
• Implementing siRNA sequences from biological experiments instead of using siRNA 
sequence design software. 
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• Experiments on more gene families. 
• Designing a more evolutionary heuristic method. 
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